Skip to main content

MTBC Practice Pulse Shows Telehealth Adoption Surging Amidst COVID-19 Crisis

MTBC and CareCloud Release Initial Findings from New COVID-19 Practice Impact Survey and Operational DataSOMERSET, N.J., April 13, 2020 (GLOBE NEWSWIRE) — MTBC, Inc. (Nasdaq: MTBC) (Nasdaq: MTBCP), a leading provider of cloud-based healthcare IT solutions and services, including telehealth, is helping medical groups stay informed and quickly address those areas posing the biggest risk to their practices during the COVID-19 pandemic. Initial findings show that practices are most focused on staying in close contact with patients, migrating in-office visits to telehealth and protecting patients and staff from infection.MTBC and CareCloud’s COVID-19 Practice Pulse provides a current snapshot of physician concerns and actions they are taking during the pandemic. Through a combination of medical practice operations data and surveying an extensive number of practices in their COVID-19 Practice Impact Survey, MTBC has identified and highlighted the current challenges and opportunities facing the industry during the pandemic.Key insights from the COVID-19 Practice Pulse include:61% of practices have converted to full or partial telehealth-based practices;
 
Telehealth appointments have increased by more than 200x as a percentage of all appointments, from less than 0.1% during the first week of March 2020 to 20% by the end of March 2020;
 
Urologists, Dermatologists and Mental/Behavioral Health clinicians are leading in telehealth adoption, with each specialty seeing 25% to 40% of their patients in recent weeks through a telehealth solution;
 
69% of practices indicate they need expedited insurance payer reimbursements in order to remain viable and to resume full operations after the COVID -19 crisis subsides;
 
63% of practices view cash flow as their most pressing need during the COVID-19 crisis, followed by telehealth at 48% and personal protective equipment at 43%; and
 
In-person appointment cancellations surged in mid-March 2020 as COVID-19 mitigation efforts spread throughout the country, with the highest reported rate of cancellations in Pennsylvania at 48% and New York and California each at 43%. Additionally, 70% of survey respondents anticipated significant decreases in patient volume.“Practices are facing unprecedented challenges to maintain their patients’ well-being and the health of their business,” said Daniel Masvidal, CareCloud’s VP Client Success. He continued, “We are helping them do both with timely, valuable information and tools ranging from telehealth to services that help improve cash flow and help them adapt. Whether we’re helping practices apply for three-month payment advances from Medicare, understanding the new, potentially forgivable payroll loans available under the Payment Protection Program (“PPP”), or leveraging our proprietary cash flow management tools, we’re providing critical support to our clients across the country as they focus on helping our nation battle COVID-19.”“Since more than 60% of practices are just beginning to use telehealth, we see a significant addressable market emerging,” said Shruti Patel, President of MTBC’s Telehealth Division. “The urgency and temporary relaxation of HIPAA requirements has caused many providers to initially use familiar technology such as FaceTime and Zoom, but we believe they will continue converting to integrated and secure telehealth technology, such as our newly launched CareCloud Live and MTBC talkPHR platforms, which enable more secure, efficient and effective care delivery.”“While most industries, including ours, are facing significant headwinds, we are striving to make a positive impact in the midst of these challenges,” said Bill Korn, MTBC CFO. “We have seen telehealth adoption accelerate, enabling the continuation of care delivery during the pandemic, and we are thankful for the privilege of supporting our clients in a multitude of other ways. We are also seeing more opportunities to assist other vendors through MTBC Force and potential acquisitions, which could enable us to assist other companies that are struggling to meet the needs of their healthcare provider clients, while also supporting our growth objectives.”Additional data and insights from the COVID-19 Practice Pulse are available here.About MTBCMTBC, Inc. is a healthcare information technology company that provides a fully integrated suite of proprietary cloud-based solutions, together with related business services, to healthcare providers and hospitals throughout the United States. Our integrated Software-as-a-Service (or SaaS) platform helps our customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs. MTBC’s common stock trades on the Nasdaq Global Market under the ticker symbol “MTBC,” and its Series A Preferred Stock trades on the Nasdaq Global Market under the ticker symbol “MTBCP.”For additional information, please visit our website at www.mtbc.com. To view MTBC’s latest investor presentation, read recent articles, and listen to interviews with management, please visit ir.mtbc.com/events.Follow MTBC on LinkedInTwitter and Facebook.SOURCE MTBCCompany Contact:
Bill Korn
Chief Financial Officer
MTBC, Inc.
bkorn@mtbc.com
Investor Contact:
Matt Kreps, Managing Director
Darrow Associates Investor Relations
mkreps@darrowir.com
(214) 597-8200

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.